These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3801451)

  • 21. Kringle solution structures via NMR: two-dimensional 1H-NMR analysis of horse plasminogen kringle 4.
    Cox M; Schaller J; Boelens R; Kaptein R; Rickli E; Llinás M
    Chem Phys Lipids; 1994 Jan; 67-68():43-58. PubMed ID: 8187244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ligand specificity of human plasminogen kringle 4.
    Rejante MR; Byeon IJ; Llinás M
    Biochemistry; 1991 Nov; 30(46):11081-92. PubMed ID: 1657159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of ligand-binding to the kringle 4 fragment from human plasminogen.
    De Marco A; Petros AM; Laursen RA; Llinás M
    Eur Biophys J; 1987; 14(6):359-68. PubMed ID: 3036485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation, purification and 1H-NMR characterization of a kringle 5 domain fragment from human plasminogen.
    Thewes T; Ramesh V; Simplaceanu EL; Llinás M
    Biochim Biophys Acta; 1987 Apr; 912(2):254-69. PubMed ID: 3030435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant gene expression and 1H NMR characteristics of the kringle (2 + 3) supermodule: spectroscopic/functional individuality of plasminogen kringle domains.
    Söhndel S; Hu CK; Marti D; Affolter M; Schaller J; Llinás M; Rickli EE
    Biochemistry; 1996 Feb; 35(7):2357-64. PubMed ID: 8652577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1H-NMR assignments and secondary structure of human plasminogen kringle 1.
    Rejante MR; Llinás M
    Eur J Biochem; 1994 May; 221(3):927-37. PubMed ID: 8181475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the aromatic 1H NMR spectrum of chicken plasminogen kringle 4.
    Petros AM; Gyenes M; Patthy L; Llinás M
    Arch Biochem Biophys; 1988 Jul; 264(1):192-202. PubMed ID: 2840024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solution structure of the tissue-type plasminogen activator kringle 2 domain complexed to 6-aminohexanoic acid an antifibrinolytic drug.
    Byeon IJ; Llinás M
    J Mol Biol; 1991 Dec; 222(4):1035-51. PubMed ID: 1762144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Solution structure and dynamics of the plasminogen kringle 2-AMCHA complex: 3(1)-helix in homologous domains.
    Marti DN; Schaller J; Llinás M
    Biochemistry; 1999 Nov; 38(48):15741-55. PubMed ID: 10625440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-type plasminogen activator domain-deletion mutant BM 06.022: modular stability, inhibitor binding, and activation cleavage.
    Hu CK; Kohnert U; Wilhelm O; Fischer S; Llinás M
    Biochemistry; 1994 Oct; 33(39):11760-6. PubMed ID: 7918392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NMR studies of 1H resonances in the 10-18-ppm range for cytosolic aspartate aminotransferase.
    Metzler DE; Metzler CM; Mollova ET; Scott RD; Tanase S; Kogo K; Higaki T; Morino Y
    J Biol Chem; 1994 Nov; 269(45):28017-26. PubMed ID: 7961736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1H NMR studies on bovine cyclophilin: preliminary structural characterization of its complex with cyclosporin A.
    Heald SL; Harding MW; Handschumacher RE; Armitage IM
    Biochemistry; 1990 May; 29(18):4466-78. PubMed ID: 2190633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton magnetic resonance characterization of phoratoxins and homologous proteins related to crambin.
    Lecomte JT; Kaplan D; Llinás M; Thunberg E; Samuelsson G
    Biochemistry; 1987 Feb; 26(4):1187-94. PubMed ID: 3567163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysine-50 is a likely site for anchoring the plasminogen N-terminal peptide to lysine-binding kringles.
    An SS; Carreño C; Marti DN; Schaller J; Albericio F; Llinas M
    Protein Sci; 1998 Sep; 7(9):1960-9. PubMed ID: 9761476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural/functional properties of the Glu1-HSer57 N-terminal fragment of human plasminogen: conformational characterization and interaction with kringle domains.
    An SS; Marti DN; Carreño C; Albericio F; Schaller J; Llinas M
    Protein Sci; 1998 Sep; 7(9):1947-59. PubMed ID: 9761475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solution structure of the epsilon-aminohexanoic acid complex of human plasminogen kringle 1.
    Rejante MR; Llinás M
    Eur J Biochem; 1994 May; 221(3):939-49. PubMed ID: 8181476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR spectroscopy of exchangeable protons of glucoamylase and of complexes with inhibitors in the 9-15-ppm range.
    Firsov LM; Neustroev KN; Aleshin AE; Metzler CM; Metzler DE; Scott RD; Stoffer B; Christensen T; Svensson B
    Eur J Biochem; 1994 Jul; 223(1):293-302. PubMed ID: 8033904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macro- and micro-stabilities of the kringle 4 domain from plasminogen. The effect of ligand binding.
    De Marco A; Motta A; Llinás M; Laursen RA
    Biophys J; 1985 Sep; 48(3):411-22. PubMed ID: 4041537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solution structure of the kringle 4 domain from human plasminogen by 1H nuclear magnetic resonance spectroscopy and distance geometry.
    Atkinson RA; Williams RJ
    J Mol Biol; 1990 Apr; 212(3):541-52. PubMed ID: 2157850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor from the mouse. Structural characterization by proton nuclear magnetic resonance and nuclear overhauser experiments at 500 MHz.
    Mayo KH
    Biochemistry; 1984 Aug; 23(17):3960-73. PubMed ID: 6333250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.